RSS Follow Become a Fan

Recent Posts

OCD Treatment with CBT and ERP
A Work in Progress: Greater Collaboration and Seamless Integration of Healthcare Delivery Services as Provider Networks and Holding Companies Expand.
Opioids: Last Week Tonight with John Oliver
Billy Joel Believes his Problem Drinking is a Symptom of Depression, Rather than the Other Way Around
Warriors of Dignity

Most Popular Posts

"It's time to stop trying to fit a square peg into a round hole in addiction treatment."
OCD Treatment with CBT and ERP
A New Trend: Smoking Alcohol
Music Video Depicts the Hellish Reality of Battling Drug Addiction
Billy Joel Believes his Problem Drinking is a Symptom of Depression, Rather than the Other Way Around


"Do 12 Step Meetings Cause Suicide?"
Addiction and Pain Management
Addiction Industry Review
Addiction Recovery
Addiction Symposiums and Presentations
Alcohol Use Disorders
Alcohol Use Disorders and Age
Alternatives for 12 Step Members Who Experience Harm in the Fellowship
Behavior Modification and Addiction Treatment
Co-Occurring Disorders
Dangerous New Trends
Dis-empowering Substance Users with Ridiculous Mandates
DOGMA: Rigid unchanging beliefs vs. Openness to New Ideas to Promote Change
Empowering Healthcare
Empowering Psychotherapy and Corporate Services - Focused on Addictions, Anxiety, OCD, Trauma &
Empowering Psychotherapy, Addictions and Corporate Services
Empowerment and Wellness
Generous American
Harm Reduction Treatment
healthcare reform
High Rate of Veteran Suicides Linked to PTSD
Implants Being Developed For Military to Monitor and Treat PTSD and Addiction
Ketamine Infusion
MICA and Co-occurring Disorders
New Addiction Research Findings
News in addiction treatment
Obsessive Compulsive Disorder
Opioid Addiction Epidemic
Prescription Drug Abuse Epidemic
PTSD and Suicide
Public Health
Scott W. Stern, Psychotherapist/Empowerment Professional
Steroid Use Disorders
Stigma and Addiction
Substance Use Disorders and Post Traumatic Stress
The Workplace and Mental Health
Treatment Alternatives Need to be Researched for Addictions
TSF (12 Step Facilitation) Treatment
powered by

Articles, News and Blog

New Addiction Research Findings

"New Research Targets AMPA Receptor for Cocaine Addiction"

Researchers isolate target for therapies to treat cocaine addiction "The critical role of the AMPA receptor in cocaine addiction is clear," said Dr. Ghazaleh Sadri-Vakili.

BOSTON, Oct. 29 (UPI) -- A new study by researchers at Massachusetts General Hospital suggests a newly identified neural target is key in contributing to cocaine cravings following a period of abstinence.

A litany of genes and neural receptors have been implicated in the science of addiction. But in studying the behaviors of lab mice, scientists found that by simply by manipulating a receptor protein that influences cravings -- a protein known as the AMPA receptor -- they could diminish the likelihood of a drug relapse.

"The critical role of the AMPA receptor in cocaine addiction is clear," Dr. Ghazaleh Sadri-Vakili, director of the NeuroEpigenetics Laboratory at Mass General and senior author of the new study, explained in a press release. "We have known that activation of the AMPA receptor in the nucleus accumbens -- an area of the brain important for drug addiction -- promotes the resumption of cocaine seeking in animal models, and this study identifies an increased contribution of calcium-permeable AMPA receptors to this process."

In their research, scientists at Mass General the University of Pennsylvania found chronic cocaine use changed the makeup of AMPA receptors in the rodents' brains. As part of the study, mice were given cocaine for 21 days, then were withheld from the drug for 10 days. After their cocaine binge, the mice were found to have less of a particular component that controls the receptors calcium-permeability.

In isolating one of the major neural components in the processes of addiction, self control and relapse, researcher were also able to finger a route to reversing the damage down to the augmented receptors.

After the ten days of abstinence, researchers gave half the mice an enzyme, called ADAR2, that replenished the component of the receptors that had previously been diminished by cocaine use. As a result of the increased presence of the enzyme, the receptor was normalize and the mice were less likely to relapse than those without the enzyme therapy.
The findings were detailed in a study published this week in the journal Molecular Psychiatry.